United States · Exchanges & live quotes · Nasdaq

Equillium Q3 Loss Widens On Higher R&D Expenses

Published by Nasdaq · United States 35 min ago

Detailed summary

(RTTNews) - Equillium, Inc., (EQ), a clinical-stage biotechnology company, reported a wider loss in its third quarter compared to last year, mainly due to higher research &…

Read the full article on Nasdaq Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.nasdaq.com)

Also worth reading

OilPrice.com

Iran Says Gas Tanker Hit Mine in Strait of Hormuz

Investopedia

Markets News, Nov. 12, 2026: Major Stock Indexes Fall as Investors Digest News of Nvidia CEO Jensen Huang’s Exit; AMD, Broadcom Soar

Google Finance

خلاصه بازار ایالات متحده

Cboe Global Markets

Market Metrics That Matter: Derivatives October 2026 Volume Highlights

CNN Markets